|14 Nov 2022||14:00 - 16:30||Online|
We are excited to launch the second year of the Cambridge-Harvard Right to Science Study Group with a discussion of the 2022 UNESCO Brief on the Right to Science and COVID-19.
This landmark document is available to read online for free. Research group leaders Helle Porsdam (University of Copenhagen) and Sebastian Porsdam Mann (University of Oxford) will host a panel of participants to discuss their contributions to this brief and take questions from the audience.
Attendance is free but spaces may be limited, so please reserve a space in the Zoom audience via online booking. We aim to record all online events, which may include any questions and responses delivered by the audience. You are welcome to submit questions via the chat box at any time.
gloknos is initially funded for 5 years by the European Research Council through a Consolidator Grant awarded to Dr Inanna Hamati-Ataya for her project ARTEFACT (2017-2022). ARTEFACT is funded by the European Research Council under the European Union’s Horizon 2020 Framework Programme for Research and Innovation (ERC grant agreement no. 724451). For information about gloknos or ARTEFACT please contact us.
Helle Porsdam and Sebastian Porsdam Mann
Abdul Kadir H. Mohammed
|15:50 - 16:30|
Q&A with audience
About the Speakers
Yusuke Mori is Director General for Policy Innovation Department at the City of Tsukuba, the biggest science city of Japan. He is in charge of comprehensive management strategy planning, science and technology promotion, digitisation of the city government, smart city development, and promotion of SDGs.
He is also Visiting Associate Professor in the Faculty of Engineering, Information and Systems at the University of Tsukuba.
Christine Mitchell is Executive Director of the Centre for Bioethics and Lecturer, Dept. of Global Health and Social Medicine, Harvard Medical School.
Christine Mitchell founded the clinical ethics program at Boston Children’s Hospital, directing the ethics consultation service and leading the Ethics Advisory Committee for over 30 years. At Harvard Medical School, where she is Executive Director of the Centre for Bioethics, which she helped to launch in 2014, Mitchell developed the Capstone program for Master of Bioethics students, Consortia on Clinical Ethics and Research Ethics, and the Leadership Group of ethics committees at 16 Harvard-affiliated teaching hospitals.
Abdul Kadir H. Mohammed recently retired from Linnaeus University, Växjö, Sweden, where he was Professor of Biological Psychology. He has published more than 100 scientific publications and did seminal work on the impact of environmental enrichment on brain and behaviour at adulthood and during aging.
He leads the SAGE (Successful AGing and Enrichment) project which involves collaboration between Linnaeus University, Karolinska Institute, Harvard Medical School and Medical University of South Carolina. He is a Fellow of the Linnean Society of London, and has served for 6 years as Chair of African Regional Committee of the International Brain Research Organization (IBRO).
Helle Porsdam is Professor of Law and Humanities at the Centre for Interdisciplinary Studies of Law (CIS), Faculty of Law, University of Copenhagen. She teaches American Culture and History in the SAXO Department, Faculty of the Humanities, University of Copenhagen, and Law and Humanities, the Culture and History of Human Rights and Cultural Rights at the Faculty of Law. She also holds a UNESCO Chair in Cultural Rights.
Sebastian Porsdam Mann is a researcher and DPhil student at the Faculty of Law at Oxford. Following undergraduate (philosophy, psychology, and neuroscience) and graduate (PhD, neuroethics) studies at Cambridge, he held postdoctoral fellowships at Harvard Medical School’s Center for Bioethics and, supported by a Carlsberg Foundation grant, the Uehiro Center for Ethics at Oxford as well as Copenhagen University. In addition to the human right to science, Sebastian’s research interest span across blockchain and data ethics, cognitive enhancement, the ethics of modifying lifeforms, and ethical aspects of clinical proteomics.